litlas
Log inCreate account

Raphael Mechoulam

Active 1963–2022

188
Papers
49,105
Citations
118
h-index
188
i10-index

Citations

Citations per year for Raphael Mechoulam1966: 5 citations1967: 23 citations1968: 2 citations1969: 12 citations1970: 16 citations1971: 16 citations1972: 14 citations1973: 20 citations1974: 6 citations1975: 10 citations1976: 5 citations1978: 3 citations1979: 4 citations1980: 1 citations1981: 5 citations1982: 6 citations1983: 2 citations1984: 5 citations1985: 1 citations1986: 5 citations1987: 4 citations1988: 7 citations1989: 1 citations1990: 14 citations1991: 17 citations1992: 12 citations1993: 50 citations1994: 58 citations1995: 147 citations1996: 128 citations1997: 190 citations1998: 328 citations1999: 276 citations2000: 334 citations2001: 339 citations2002: 505 citations2003: 421 citations2004: 382 citations2005: 618 citations2006: 490 citations2007: 587 citations2008: 574 citations2009: 465 citations2010: 494 citations2011: 583 citations2012: 529 citations2013: 448 citations2014: 425 citations2015: 543 citations2016: 536 citations2017: 585 citations2018: 518 citations2019: 1,445 citations2020: 1,795 citations2021: 1,756 citations2022: 1,225 citations2023: 862 citations2024: 1,131 citations2025: 366 citations2026: 3 citations1977: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,177 citing papers, 27.3% of this breakdownItaly: 1,032 citing papers, 8.9% of this breakdownUnited Kingdom: 785 citing papers, 6.8% of this breakdownCanada: 632 citing papers, 5.4% of this breakdownSpain: 565 citing papers, 4.9% of this breakdownGermany: 537 citing papers, 4.6% of this breakdownChina: 477 citing papers, 4.1% of this breakdownIsrael: 411 citing papers, 3.5% of this breakdownBrazil: 369 citing papers, 3.2% of this breakdownAustralia: 364 citing papers, 3.1% of this breakdownFrance: 262 citing papers, 2.3% of this breakdownJapan: 246 citing papers, 2.1% of this breakdown
0%27.3%Other 23.8%

Institutions

Fields

  • Medicine82.7%
  • Biochemistry, Genetics and Molecular Biology5.5%
  • Neuroscience5.5%
  • Pharmacology, Toxicology and Pharmaceutics1.5%
  • Agricultural and Biological Sciences1.3%
  • Immunology and Microbiology0.8%
  • Other2.7%

Topics

  • Cannabis and Cannabinoid Research26.2%
  • Neuroscience and Neuropharmacology Research6.8%
  • Neurotransmitter Receptor Influence on Behavior5.5%
  • Sleep and Wakefulness Research4%
  • Forensic Toxicology and Drug Analysis3.7%
  • GABA and Rice Research3.1%
  • Other50.7%

Coauthors

All papers

Open in search
  1. Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

    Authors: William A. Devane, Lumir Hanuš, Aviva Breuer, Roger G. Pertwee, Lesley Stevenson, Graeme Griffin, Dan Gibson, Asher Mandelbaum, Alexander Etinger, Raphael Mechoulam - Science 1992 cited by 5,647

  2. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

    Authors: Tiziana Bisogno, Lumír Hanuš, Luciano De Petrocellis, Susanna Tchilibon, Datta E. Ponde, Ines Brandi, Aniello Schiano Moriello, John B. Davis, Raphael Mechoulam, Vincenzo Di Marzo - British Journal of Pharmacology 2001 cited by 1,306

  3. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

    Authors: Raphael Mechoulam, Shimon Ben‐Shabat, L Hanŭs, M. Ligumsky, Norbert E. Kaminski, Anthony R. Schatz, Asher Gopher, Shlomo Almog, Billy R. Martin, David R. Compton, Roger G. Pertwee, Graeme Griffin, Michael Bayewitch, Jacob Barg, Zvi Vogel - Biochemical Pharmacology 1995 cited by 2,901

  4. The Endocannabinoid System and the Brain

    Authors: Raphael Mechoulam, Linda A. Parker - Annual Review of Psychology 2012 cited by 1,084

  5. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

    Authors: Roger G. Pertwee, A­llyn C. Howlett, Mary E. Abood, S P H Alexander, Vincenzo Di Marzo, Maurice R. Elphick, Peter J. Greasley, Harald S. Hansen, George Kunos, Ken Mackie, Raphael Mechoulam, Ruth A. Ross - Pharmacological Reviews 2010 cited by 1,583

  6. Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy

    Authors: Mohanraj Rajesh, Partha Mukhopadhyay, Sándor Bátkai, Vivek Patel, Keita Saito, Shingo Matsumoto, Yoshihiro Kashiwaya, Béla Horváth, Bani Mukhopadhyay, Lauren Becker, György Haskó, Lucas Liaudet, David A. Wink, Aristidis Veves, Raphael Mechoulam, Pál Pacher - Journal of the American College of Cardiology 2010 cited by 490

  7. Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer’s Disease

    Authors: Ana M. Martín‐Moreno, David Reigada, Belén G. Ramírez, Raphael Mechoulam, Nadia G. Innamorato, Antonio Cuadrado, Marı́a L. de Ceballos - Molecular Pharmacology 2011 cited by 394

  8. Hashish—I

    Authors: Raphael Mechoulam, Youval Shvo - Tetrahedron 1963 cited by 479

  9. Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

    Authors: Yehiel Gaoni, Raphael Mechoulam - Journal of the American Chemical Society 1964 cited by 2,377

  10. Endocannabinoid signaling at the periphery: 50 years after THC

    Authors: Mauro Maccarrone, Itai Bab, Tamás Bı́ró, Guy A. Cabral, Sudhansu K. Dey, Vincenzo Di Marzo, Justin C. Konje, George Kunos, Raphael Mechoulam, Pál Pacher, Keith A. Sharkey, Andreas Zimmer - Trends in Pharmacological Sciences 2015 cited by 641

  11. Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test

    Authors: Ila Marques Porto Linares, Antônio Waldo Zuardi, Luis C. Pereira, Regina Helena Costa Queiróz, Raphael Mechoulam, Francisco Silveira Guimarães, José Alexandre S. Crippa - Brazilian Journal of Psychiatry 2018 cited by 233

  12. Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis

    Authors: Enkui Hao, Partha Mukhopadhyay, Zongxian Cao, Katalin Erdélyi, Eileen Holovac, Lucas Liaudet, Wen-Shin Lee, György Haskó, Raphael Mechoulam, Pál Pacher - Molecular Medicine 2015 cited by 175

  13. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

    Authors: Anne‐Marie Malfait, Ruth Gallily, Percy F. Sumariwalla, Angela Sara Malik, Evangelos Andreakos, Raphael Mechoulam, Marc Feldmann - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 cited by 663

  14. Cannabidiol – Recent Advances

    Authors: Raphael Mechoulam, Maximilian Peters, Eric Murillo‐Rodríguez, Lumír O. Hanuš - Chemistry & Biodiversity 2007 cited by 512

  15. Cannabidiol: An Overview of Some Pharmacological Aspects

    Authors: Raphael Mechoulam, Linda A. Parker, Ruth Gallily - The Journal of Clinical Pharmacology 2002 cited by 506

  16. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

    Authors: Angelo A. Izzo, Francesca Borrelli, Raffaele Capasso, Vincenzo Di Marzo, Raphael Mechoulam - Trends in Pharmacological Sciences 2009 cited by 816

  17. Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects

    Authors: Raphael Mechoulam, Lumı́r Hanuš - Chemistry and Physics of Lipids 2002 cited by 251

  18. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease

    Authors: Isabel Lastres‐Becker, Francisco Molina‐Holgado, J.A. Ramos, Raphael Mechoulam, Javier Fernández‐Ruíz - Neurobiology of Disease 2005 cited by 410

  19. Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

    Authors: Javier Fernández‐Ruíz, Onintza Sagredo, M. Ruth Pazos, Concepción García, Roger G. Pertwee, Raphael Mechoulam, José Martínez‐Orgado - British Journal of Clinical Pharmacology 2012 cited by 343

  20. Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death

    Authors: Partha Mukhopadhyay, Mohanraj Rajesh, Béla Horváth, Sándor Bátkai, Ogyi Park, Galin Tanchian, Rachel Y. Gao, Vivek Patel, David A. Wink, Lucas Liaudet, György Haskó, Raphael Mechoulam, Pál Pacher - Free Radical Biology and Medicine 2011 cited by 199

  21. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity

    Authors: Shimon Ben‐Shabat, Ester Fride, Tzviel Sheskin, Tsippy Tamiri, Man Hee Rhee, Zvi Vogel, Tiziana Bisogno, Luciano De Petrocellis, Vincenzo Di Marzo, Raphael Mechoulam - European Journal of Pharmacology 1998 cited by 621

  22. HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor

    Authors: L Hanŭs, Aviva Breuer, Susanna Tchilibon, S. Shiloah, Dalia Goldenberg, Mark Horowitz, Roger G. Pertwee, Ruth A. Ross, Raphael Mechoulam, Ester Fride - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 568

  23. Early phytocannabinoid chemistry to endocannabinoids and beyond

    Authors: Raphael Mechoulam, Lumír O. Hanuš, Roger G. Pertwee, A­llyn C. Howlett - Nature reviews. Neuroscience 2014 cited by 382

  24. Cannabidiol—transdermal delivery and anti-inflammatory effect in a murine model

    Authors: M Lodzki, Biana Godin, L Rakou, Raphael Mechoulam, Ruth Gallily, Elka Touítou - Journal of Controlled Release 2003 cited by 267